Phase III Study of Intravenous Tramadol for the Management of Post-Operative Pain in Patients Undergoing Bunionectomy Surgery
Phase of Trial: Phase III
Latest Information Update: 09 Aug 2017
At a glance
- Drugs Tramadol (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 09 Aug 2017 According to a Fortress Biotech media release, Avenue Therapeutics (subsidiary of Fortress Biotech) is on track to initiate this trial in the third quarter of 2017.
- 09 Aug 2017 Planned initiation date changed from 31 Jan 2017 to 1 Sep 2017, according to a Fortress Biotech media release.
- 16 Mar 2017 According to a Fortress Biotech media release, this is one of three phase III trials of IV tramadol for the management of post-operative pain.